Suppr超能文献

慢性心包积液:病因与处理。

Chronic Pericardial Effusion: Causes and Management.

机构信息

First Cardiology Clinic, Hippokration General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Cardiology, Cardiothoracic Department, University Hospital "Santa Maria della Misericordia", ASUFC, Udine, Italy.

出版信息

Can J Cardiol. 2023 Aug;39(8):1121-1131. doi: 10.1016/j.cjca.2023.02.003. Epub 2023 Feb 10.

Abstract

Chronic pericardial effusion is a common pericardial syndrome whose approach has been well standardised in recent years. The main challenge associated with this condition is the progression (sometimes unheralded) to cardiac tamponade. Pericardial effusions may present either as an isolated finding or in the context of a specific etiology including autoimmune, neoplastic, or metabolic disease. Among investigations used during diagnostic work-up, echocardiography is of paramount importance for the diagnosis, sizing, and serial evaluation of the hemodynamic impact of effusions on heart diastolic function. In an individualised manner, advanced imaging including computed tomography and cardiac magnetic resonance imaging should be performed, especially if baseline tests are inconclusive. Triage of these patients according to the most recent 2015 European Society of Cardiology Guidelines for the diagnosis and management of pericardial diseases should take into account the presence of hemodynamic compromise as well as suspicion of malignant or purulent pericarditis as first step, C-reactive protein serum level measurement as second step, investigations for a specific condition known to be associated with pericardial effusion as third step, and finally the size and the duration of the effusion. Treatment depends on the evaluation of the above-mentioned parameters and should ideally be tailored to the individual patient. Prognosis of chronic pericardial effusions depends largely on the underlying etiology. According to novel data, the prognosis of individuals with idiopathic, chronic (> 3 months), large (> 2 cm), asymptomatic pericardial effusions is usually benign and a watchful waiting strategy seems more reasonable and cost-effective than routine drainage as previously recommended.

摘要

慢性心包积液是一种常见的心包综合征,近年来其治疗方法已经得到了很好的规范。与这种疾病相关的主要挑战是进展(有时是无症状的)为心脏压塞。心包积液可能表现为孤立性发现,也可能是特定病因的表现,包括自身免疫性、肿瘤性或代谢性疾病。在诊断性检查中,超声心动图对于诊断、心包积液大小的评估以及心包积液对心脏舒张功能的血流动力学影响的连续评估具有至关重要的作用。应根据具体情况进行高级影像学检查,包括计算机断层扫描和心脏磁共振成像,特别是如果基线检查结果不确定。根据 2015 年欧洲心脏病学会心包疾病诊断和管理指南的最新版本,这些患者的分诊应考虑血流动力学受损的存在,以及恶性或化脓性心包炎的可疑性,作为第一步,第二步是测量 C 反应蛋白血清水平,第三步是针对已知与心包积液相关的特定情况进行检查,最后是积液的大小和持续时间。治疗取决于对上述参数的评估,理想情况下应根据个体患者进行定制。慢性心包积液的预后在很大程度上取决于潜在病因。根据新的数据,特发性、慢性(>3 个月)、大(>2cm)、无症状心包积液患者的预后通常是良性的,与以前建议的常规引流相比,观察等待策略似乎更合理且更具成本效益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验